ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2085415
下载链接
链接失效反馈官方服务：
资源简介：
ARQ 197 or placebo in combination with irinotecan and cetuximab in participants with metastatic colorectal cancer (CRC), in participants with wild-type KRAS alleles who have failed front-line systemic therapy, to evaluate the safety, tolerability, and efficacy of ARQ 197, define the recommended dose for Phase 2.
After the recommended dose is determined for Phase 2, participants receive study drug or placebo with irinotecan and cetuximab.
创建时间：
2010-01-15
